Search research articles
Contact Us
Filters
Showing results (71-80 of 239) with videos related to
Page
of 24
Sort By:
Digestion
|
November 19, 2018
Risk Factors for Delayed Hemorrhage after Colonic Endoscopic Mucosal Resection in Patients Not on Antithrombotic Therapy: Retrospective Analysis of 3,844 Polyps of 1,660 Patients
Sanae Tsuruta, Naoyuki Tominaga, Shinichi Ogata, et al.
Biochimica Et Biophysica Acta
|
May 18, 2010
Regulation of tumor suppressor PDCD4 by novel protein kinase C isoforms
Mayumi Nakashima, Hiroshi Hamajima, Jinghe Xia, et al.
Clinical Biochemistry
|
May 7, 2014
Uric acid levels decrease with fibrosis progression in patients with nonalcoholic fatty liver disease
Masato Yoneda, Emmanuel Thomas, Yoshio Sumida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 31, 2015
Sarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatment
Saori Kamachi, Toshihiko Mizuta, Taiga Otsuka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 18, 2014
Clinical usage of serum ferritin to assess liver fibrosis in patients with non-alcoholic fatty liver disease: Proceed with caution
Masato Yoneda, Emmanuel Thomas, Yoshio Sumida, et al.
Journal of Medical Economics
|
March 24, 2025
Patient and physician preferences for treatment of hepatitis C virus infection in Japan: a discrete choice experiment
Daisuke Nakamoto, Yi Piao, Hajime Mizutani, et al.
Alimentary Pharmacology & Therapeutics
|
September 16, 2021
Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), versus placebo in patients with non-alcoholic fatty liver disease
Atsushi Nakajima, Yuichiro Eguchi, Masato Yoneda, et al.
Journal of Clinical Biochemistry and Nutrition
|
April 26, 2008
Radiofrequency ablation with the real-time virtual sonography system for treating hepatocellular carcinoma difficult to detect by ultrasonography
Hiroaki Kawasoe, Yuichiro Eguchi, Toshihiko Mizuta, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 28, 2018
Epidemiological survey of hemoglobin A1c and liver fibrosis in a general population with non-alcoholic fatty liver disease
Kenichi Tanaka, Hirokazu Takahashi, Hideyuki Hyogo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
December 10, 2003
Induction of multiple matrix metalloproteinase genes in human hepatocellular carcinoma by hepatocyte growth factor via a transcription factor Ets-1
Iwata Ozaki, Toshihiko Mizuta, Gang Zhao, et al.
Page
of 24
Search research articles
Search
Showing results (71-80 of 239) with videos related to
Sort By:
Page
of 24
Digestion
|
November 19, 2018
Risk Factors for Delayed Hemorrhage after Colonic Endoscopic Mucosal Resection in Patients Not on Antithrombotic Therapy: Retrospective Analysis of 3,844 Polyps of 1,660 Patients
Sanae Tsuruta, Naoyuki Tominaga, Shinichi Ogata, et al.
Biochimica Et Biophysica Acta
|
May 18, 2010
Regulation of tumor suppressor PDCD4 by novel protein kinase C isoforms
Mayumi Nakashima, Hiroshi Hamajima, Jinghe Xia, et al.
Clinical Biochemistry
|
May 7, 2014
Uric acid levels decrease with fibrosis progression in patients with nonalcoholic fatty liver disease
Masato Yoneda, Emmanuel Thomas, Yoshio Sumida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 31, 2015
Sarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatment
Saori Kamachi, Toshihiko Mizuta, Taiga Otsuka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 18, 2014
Clinical usage of serum ferritin to assess liver fibrosis in patients with non-alcoholic fatty liver disease: Proceed with caution
Masato Yoneda, Emmanuel Thomas, Yoshio Sumida, et al.
Journal of Medical Economics
|
March 24, 2025
Patient and physician preferences for treatment of hepatitis C virus infection in Japan: a discrete choice experiment
Daisuke Nakamoto, Yi Piao, Hajime Mizutani, et al.
Alimentary Pharmacology & Therapeutics
|
September 16, 2021
Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), versus placebo in patients with non-alcoholic fatty liver disease
Atsushi Nakajima, Yuichiro Eguchi, Masato Yoneda, et al.
Journal of Clinical Biochemistry and Nutrition
|
April 26, 2008
Radiofrequency ablation with the real-time virtual sonography system for treating hepatocellular carcinoma difficult to detect by ultrasonography
Hiroaki Kawasoe, Yuichiro Eguchi, Toshihiko Mizuta, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 28, 2018
Epidemiological survey of hemoglobin A1c and liver fibrosis in a general population with non-alcoholic fatty liver disease
Kenichi Tanaka, Hirokazu Takahashi, Hideyuki Hyogo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
December 10, 2003
Induction of multiple matrix metalloproteinase genes in human hepatocellular carcinoma by hepatocyte growth factor via a transcription factor Ets-1
Iwata Ozaki, Toshihiko Mizuta, Gang Zhao, et al.
Page
of 24